Maher K. Gandhi
- Oncology top 1%
- Viral-associated cancers and disorders 37
- CAR-T cell therapy research 22
- Cancer Immunotherapy and Biomarkers 21
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment 82
- Immunology top 1%
- Immune Cell Function and Interaction 36
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 25
- Epidemiology top 2%
- Cytomegalovirus and herpesvirus research 15
-
- CNS Lymphoma Diagnosis and Treatment 14
- Co-authors
- Rajiv KhannaJamie P. NourseColm KeaneKimberley JonesDevinder GillFrank VariPaula MarltonJohn F. Seymour
- Journals
- Journal of Clinical Investigation (1 paper)Nature Communications (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
Maher K. Gandhi
131 papers receiving 4.4k citations
Peers
Comparison fields: 5 of 108
- Oncology 2.5k
- Pathology and Forensic Medicine 1.5k
- Immunology 1.7k
- Genetics 347
- Epidemiology 1.1k
Countries citing papers authored by Maher K. Gandhi
This map shows the geographic impact of Maher K. Gandhi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maher K. Gandhi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maher K. Gandhi more than expected).
Fields of papers citing papers by Maher K. Gandhi
This network shows the impact of papers produced by Maher K. Gandhi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maher K. Gandhi. The network helps show where Maher K. Gandhi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Maher K. Gandhi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 11 | |
| 4 | 2023 | 8 | |
| 5 | 2022 | 1 | |
| 6 | 2022 | 16 | |
| 7 | 2021 | 2 | |
| 8 | 2021 | 12 | |
| 9 | 2021 | 15 | |
| 10 | 2020 | 113 | |
| 11 | 2019 | 28 | |
| 12 | 2018 | 231 | |
| 13 | 2017 | 15 | |
| 14 | 2016 | 63 | |
| 15 | 2013 | 107 | |
| 16 | 2013 | 2 | |
| 17 | 2012 | 83 | |
| 18 | LAG-3 expressing lymphocytes suppress EBV latent membrane protein-specific T cell function in Hodgkins lymphoma patients | 2005 | 1 |
| 19 | Febrile neutropenia after hematopoietic stem cell mobilization with chemotherapy and G-CSF does not affect collection of adequate numbers of CD34+ cells. | 1997 | 2 |
| 20 | Treatment of acute myeloid leukemia (AML) at diagnosis in 99 unselected adults with high dose ARA-C (HIDAC) and mitoxantrone: Long-term follow-up. | 1996 | 1 |
About Maher K. Gandhi
Maher K. Gandhi is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics, having authored 133 papers that have together received 4.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (82 papers), Viral-associated cancers and disorders (37 papers), Immune Cell Function and Interaction (36 papers), Chronic Lymphocytic Leukemia Research (25 papers), CAR-T cell therapy research (22 papers), Cancer Immunotherapy and Biomarkers (21 papers), Cytomegalovirus and herpesvirus research (15 papers) and CNS Lymphoma Diagnosis and Treatment (14 papers). The work is most often cited by research in Oncology (2.5k citations), Pathology and Forensic Medicine (1.5k citations) and Immunology (1.7k citations). Maher K. Gandhi has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Rajiv Khanna, Jamie P. Nourse, Colm Keane, Kimberley Jones, Devinder Gill, Frank Vari, Paula Marlton, John F. Seymour, Ujjwal Dua and Michael R. Green. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.